Ipsen
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · France · 5K - 10K Employees
View Company Info for Free
Overview
Headquarters
65 Quai Georges Gorse, Boulogne-Billanco...Phone Number
+33 158335000Website
ipsen.comRevenue
$4.4 BillionStock Symbol
IPNIndustry
ZI Rank: 2
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
10
11
1
2
2
2
About Ipsen
Founded in 1929 and headquartered in Boulogne, France, Ipsen Pharma is a global biopharmaceutical group focused on specialty care. The Group develops and commercializes medicines in therapeutic areas including oncology, neuroscience, and rare diseases.Explore more
Ipsen Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Ipsen your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Ipsen has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Ipsen recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Ipsen
Ipsen, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Ipsen launches new products
Click to see if Ipsen had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Check out if Ipsen is spiking on competitors!
Funding: Get notified immidiatlly once Ipsen has new funding data
Recommended Actions
Reach out to Masked Content who joined Ipsen as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Ipsen is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Ipsen is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Ipsen.
Ipsen Tech Stack
A closer look at the technologies used by Ipsen
See more technologies
Most Recent Scoops
Open Position
Open Position
Open Position
Open Position
Open Position
Ipsen News & Media
New late-breaking data reinforces IQIRVO®’s impact on ALP, fatigue and pruritus in PBC
PARIS, FRANCE, 28 MAY 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) today announced the presentation of new late-breaking results from the ELATIVE® Phase III trial and two real-world studies at the European Association for the Study of the Liver (EASL) congress. Together, these data further strengthen the growing body of evidence establishing IQIRVO® as the only second-line primary biliary cholangitis (PBC) treatment providing rapid and robust alkaline phosphatase (ALP) reduction with fatigue improveIpsen announces late-breaking data from first head-to-head study comparing Dysport® and Botox® in adults with upper limb spasticity
PARIS, FRANCE – 19 MAY 2026 – Ipsen (Euronext: IPN; ADR: IPSEY) announced today results from the only prospective, head-to-head Phase IV DIRECTION trial comparing Dysport® (abobotulinumtoxinA) to Botox® (onabotulinumtoxinA) in adults living with upper limb spasticity (ULS)1 will be presented as a late-breaking presentation at the International Society of Physical and Rehabilitation Medicine (ISPRM) world congress in Vancouver on May 19, 2026. The trial showed that patients treated with Dysport hIpsen S.A. (IPSEY) Discusses Phase II LANTIC Data and Innovation in Engineered Neuroinhibitors for Aesthetic Indications Transcript
Ipsen S.A. (IPSEY) Discusses Phase II LANTIC Data and Innovation in Engineered Neuroinhibitors for Aesthetic Indications May 18, 2026 9:00 AM EDTCompany...Ipsen initiates a new share buy-back program
Ipsen initiates a new share buy-back program
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Ipsen
Sign Up For FreeTo access detailed company insights
Founded in 1929 and headquartered in Boulogne, France, Ipsen Pharma is a global biopharmaceutical group focused on specialty care. The Group develops and commercializes medicines in therapeutic areas including oncology, neuroscience, and rare diseases.... Read More
